5-Bromo-2-hydroxyisophthalaldehyde

Catalog No.: 
ACHAZR592
CAS No.: 
109517-99-9
Molecular Formula: 
C8H5BrO3
Molecular Weight: 
229.03
5-Bromo-2-hydroxyisophthalaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$68.00In stockInquiry
250mg95%$135.00In stockIn stock
1g95%$369.00In stockIn stock
5g95%$1322.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-hydroxyisophthalaldehyde
IUPAC Name5-bromo-2-hydroxyisophthalaldehyde
MDL No.MFCD01142867
Molecular FormulaC8H5BrO3
Molecular Weight229.03
SMILESO=CC1=CC(Br)=CC(C=O)=C1O
InChI KeyOEHFPZMUTXRLFE-UHFFFAOYSA-N
Synonym1,3-Benzenedicarboxaldehyde, 5-broMo-2-hydroxy-;5-Bromo-2-hydroxy-1,3-benzenedicarboxaldehyde;5-bromo-2-hydroxyisophthalaldehyde;5-bromo-2-hydroxybenzene-1,3-dicarbaldehyde;2,6-diformyl-4-bromophenol
CAS No.109517-99-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P403+P233-P501

Synthetic Route by SureRoute

1. ACHAZR592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDJHU602 route compound structure diagram
    ACDJHU6021761-61-1
  4. Then
  5. ACHAZR592 route product structure diagram
    ACHAZR592109517-99-9In Stock
Inquiry

2. ACHAZR592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHAZR592 route product structure diagram
    ACHAZR592109517-99-9In Stock
Inquiry

3. ACHAZR592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHAZR592 route product structure diagram
    ACHAZR592109517-99-9In Stock
Inquiry

Comments (0)